|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-1-19
|
|
pubmed:abstractText |
Orofacial granulomatosis (OFG) can be challenging to treat and experience with anti-TNF-? therapy is limited. We report our experience with infliximab (IFX) and adalimumab (ADA) for OFG in 14 patients, the largest reported series to date.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
D
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1600-0714
|
|
pubmed:author |
pubmed-author:BrostoffJonathonJ,
pubmed-author:CampbellHelenH,
pubmed-author:ChallacombeStephenS,
pubmed-author:ElliottTimT,
pubmed-author:EscudierMichaelM,
pubmed-author:LomerMirandaM,
pubmed-author:MentzerAlexA,
pubmed-author:NunesCarloC,
pubmed-author:PatelPritashP,
pubmed-author:PoateTimT,
pubmed-author:SandersonJeremyJ,
pubmed-author:ShirlawPenelopeP
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
14-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21249727-Anti-Inflammatory Agents,
pubmed-meshheading:21249727-Antibodies, Monoclonal,
pubmed-meshheading:21249727-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:21249727-Crohn Disease,
pubmed-meshheading:21249727-Female,
pubmed-meshheading:21249727-Granulomatosis, Orofacial,
pubmed-meshheading:21249727-Humans,
pubmed-meshheading:21249727-Male,
pubmed-meshheading:21249727-Statistics, Nonparametric,
pubmed-meshheading:21249727-Time Factors,
pubmed-meshheading:21249727-Treatment Outcome,
pubmed-meshheading:21249727-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Experience with anti-TNF-? therapy for orofacial granulomatosis.
|
|
pubmed:affiliation |
Department of Gastroenterology, Guy's and St. Thomas' NHS Foundation Trust and King's College London, London, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
